Latest Regulatory News

Infini Resources Limited’s I88OA securities have been suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s regulatory standing.

Cynata Therapeutics has completed the final patient visit in its Phase 3 trial for CYP-004, targeting knee osteoarthritis, with results expected in mid-2026. This milestone advances hopes for a disease-modifying therapy in a market desperate for new options.

Redcastle Resources and BML Ventures have submitted a critical Mine Development and Closure Plan for their Queen Alexandra and Redcastle Reef deposits, setting the stage for gold production to commence in early 2026.

St George Mining reports outstanding high-grade rare earth and niobium assay results from its Araxá Project in Brazil, signaling a significant resource expansion and upgrade. Ongoing drilling suggests the deposit remains open in all directions, reinforcing Araxá’s status as a world-class asset.

Santana Minerals has secured formal acceptance from New Zealand's Environmental Protection Authority for its Fast-track Approvals application, moving the Bendigo-Ophir Gold Project closer to construction.

Noronex Limited has agreed to sell its Witvlei copper project in Namibia for A$4.5 million, enabling a sharper focus on its core Kalahari Copper Belt assets and uranium exploration. The staged payment deal includes options issuance and a royalty, signaling strategic portfolio refinement.

Black Dragon Gold has completed a €2.64 million placement to Spanish high-net-worth investors, strengthening local ties and funding key engineering work for its Salave Gold Project in Asturias.

CuFe Ltd has expanded its Orlando Deposit resource at Tennant Creek by incorporating significant bismuth and silver, enhancing the project's economic potential and positioning it among Australia's largest bismuth resources.

Macquarie Asset Management has tabled a $5.20 per share cash offer to acquire Qube Holdings, valuing the logistics giant at approximately $11.6 billion. The Qube board has entered an exclusivity agreement and signals unanimous support, pending due diligence and regulatory approvals.

Island Pharmaceuticals has secured membership in the Medical Countermeasures Coalition, positioning its antiviral Galidesivir for critical US government stockpiling and regulatory milestones.

BHP Group has officially ended talks to combine with Anglo American, choosing instead to focus on its own growth strategy. The mining giant acknowledges the strategic benefits of a merger but remains confident in its independent path forward.

Osmond Resources has released confirmatory assay results from its Orión EU Critical Minerals Project in Spain, revealing high-grade titanium, zirconium, hafnium, and rare earth element mineralisation. These findings reinforce the project's potential as a globally significant source of critical minerals.